Mitral valve prolapse medical therapy

Mitral valve prolapse Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Chest X ray
CT
MRI
Echocardiography
Left ventriculography
Treatment
Medical Therapy
Surgery
Tertiary Prevention
Mitral valve prolapse medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mitral valve prolapse medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mitral valve prolapse medical therapy
CDC on Mitral valve prolapse medical therapy
Mitral valve prolapse medical therapy in the news
Blogs on Mitral valve prolapse medical therapy
Directions to Hospitals Treating Mitral valve prolapse
Risk calculators and risk factors for Mitral valve prolapse medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Most patients only need reassurance. Those with mitral valve prolapse and symptoms of dysautonomia (palpitations, chest pain) may often benefit from beta-blockers (e.g., propranolol). Patients with prior stroke and/or atrial fibrillation may require anticoagulation is, such as aspirin or warfarin.